| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 02/10/2005 | CA2534212A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 02/10/2005 | CA2533820A1 Spatially-defined macrocycles incorporating peptide bond surrogates |
| 02/10/2005 | CA2532382A1 N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 02/10/2005 | CA2518950A1 Indazole derivatives |
| 02/09/2005 | EP1505062A1 Heterocyclic derivatives and their use as antithrombotic agents |
| 02/09/2005 | EP1504003A1 Nitrosated imidazopyridines |
| 02/09/2005 | EP1503998A1 Heteroaryl substituted spirocyclic sufamides for inhibition of gamma secretase |
| 02/09/2005 | EP1503994A1 Substituted (thioxo)carbonylamino phenyl uraciles |
| 02/09/2005 | EP1503760A1 Camptothecin derivatives and polymeric conjugates thereof |
| 02/09/2005 | EP1487795A4 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 02/09/2005 | EP1349839B1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 02/09/2005 | EP1204322B1 Fungicides |
| 02/09/2005 | EP1044202B1 1'- 4- 1- (4-fluorophenyl)- 1h-indole-3-yl] -1-butyl]-spiro isobenzofuran- 1(3h),4'- piperidine] hydrohalogenides |
| 02/09/2005 | EP0941093B1 Use of nk-1 receptor antagonists for treating major depressive disorders with anxiety |
| 02/09/2005 | CN1578779A Small organic molecule regulators of cell proliferation |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
| 02/09/2005 | CN1576277A New derivatives of benzo[a]pyrano[3, 2-h]acridin-7-one, a process for their preparation and pharmaceutical compounds containing them |
| 02/09/2005 | CN1188403C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/08/2005 | US6852860 Method for making piperidone ketals using polyphosphoric acid |
| 02/08/2005 | US6852725 Imidazolyl derivatives |
| 02/03/2005 | WO2005010063A1 Vinyl monomer, polymer derived from such monomer, and a light-emitting device using such polymer |
| 02/03/2005 | WO2005010009A1 Thienopyridine and furopyridine kinase inhibitors |
| 02/03/2005 | WO2005009969A1 Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 02/03/2005 | WO2005009398A2 Tetracyclic benzamide derivatives and methods of use thereof |
| 02/03/2005 | WO2005009347A2 7-substituted camptothecin and camptothecin analogs and methods for preparing same |
| 02/03/2005 | WO2003106450A8 Phenylaminopyrimidines and their use as rho-kinase inhibitors |
| 02/03/2005 | WO2003063779A3 Selective analgesic agents |
| 02/03/2005 | US20050027130 Rhodamine dye compounds for patterns with DNA sequences for kits |
| 02/03/2005 | US20050027122 Compounds for modulators of chemokine activity |
| 02/03/2005 | US20050026944 Thienopyridine and furopyridine kinase inhibitors |
| 02/03/2005 | US20050026942 Chemokine receptor binding heterocyclic compounds |
| 02/03/2005 | US20050026929 2-Phenyl-4-(piperidin-1-ylcarbonyl)-oxazole derivatives; capsase activators; cancer, autoimmune diseases, rheumatoid arthritis, inflammatory bowel disease, or psoriasis |
| 02/03/2005 | US20050026915 As melanin concentrating hormone (MCH)receptor antagonists, for prevention or treatment of obesity or eating disorders; (2E)-3-(4-chlorophenyl)-N-[2-(dimethylamino)quinolin-6-yl]prop-2-enamide |
| 02/03/2005 | CA2532982A1 Thienopyridine and furopyridine kinase inhibitors |
| 02/03/2005 | CA2530046A1 7-substituted camptothecin and camptothecin analogs and methods for preparing same |
| 02/03/2005 | CA2517260A1 Tetracyclic benzamide derivatives and methods of use thereof |
| 02/02/2005 | EP1501841A2 Non nucleoside reverse transcriptase inhibitors |
| 02/02/2005 | EP1501837A1 Cascade esters of camptothecins and methods of treating cancer using these compounds |
| 02/02/2005 | EP1501836A1 Halo-alkyl esters of camptothecins and methods of treating cancer using these compounds |
| 02/02/2005 | EP1501835A2 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 02/02/2005 | EP1501831A1 Inhibitors of checkpoint kinases (wee1 and chk1) |
| 02/02/2005 | EP1501803A2 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 02/02/2005 | EP1501799A1 Compounds useful in preparing camptothecin derivatives |
| 02/02/2005 | EP1137413B1 Non-peptide antagonists of glp-1 receptor and methods of use |
| 02/02/2005 | CN1575292A Pharmaceutically acceptable salts of 20(s)-camptothecins |
| 02/02/2005 | CN1575172A Substituted ideno[1, 2-c]isoquinoline derivatives and methods of use thereof |
| 02/02/2005 | CN1572299A Agents for improving excretory potency of urinary bladder |
| 02/02/2005 | CN1187355C Method for refining high-purity tetradoxin |
| 02/01/2005 | US6849743 Synthesis of clasto-lactacystin β-lactone and analogs thereof |
| 02/01/2005 | US6849629 Heteroaromatic substituted sulfonyl or sulfoxide or thio-pyridazinone derivatives, useful for treating diabetic complications and cardiovascular disorders |
| 02/01/2005 | US6849627 Including interleukin-1 and Tumor Necrosis Factor; treating rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, septic shock, cardiopulmonary dysfunction, acute respiratory disease, and cachexia |
| 02/01/2005 | US6849622 May be useful for the prophylaxis and treatment of diabetes, particularly type 2 diabetes, and for prophylaxis and treatment of other diseases induced or exacerbated by impaired glucose tolerance |
| 02/01/2005 | US6849620 N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease |
| 01/27/2005 | WO2005007652A2 Substituted quinolin-4-ylamine analogues |
| 01/27/2005 | WO2005007629A1 Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity |
| 01/27/2005 | WO2005007103A2 Use of parthenolide derivatives as antileukemic and cytotoxic agents |
| 01/27/2005 | WO2005007099A2 Pkb inhibitors as anti-tumor agents |
| 01/27/2005 | WO2005007084A2 Pancratistatin cyclic phosphate prodrugs an phenpanstatin cyclic phosphate prodrugs |
| 01/27/2005 | WO2004110385A3 Modulators of the glucocorticoid receptor and method |
| 01/27/2005 | US20050020644 Bicyclic fused pyridinyl amides and advantagesous compositons thereof for use as fungicides |
| 01/27/2005 | US20050020619 Anticancer agents ; cardiovascular disorders; antiinflammatory agents;antiarthritic agents; Crohn's diseases; antiischemic agents |
| 01/27/2005 | US20050020595 Compounds, methods and pharmaceutical compositions for inhibiting PARP |
| 01/27/2005 | US20050020578 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents |
| 01/27/2005 | US20050020573 5HT2c receptor modulators |
| 01/27/2005 | US20050020481 Ion channel modulating compounds and uses thereof |
| 01/27/2005 | US20050019263 Conjugate for differentiating between healthy and unhealthy tissue |
| 01/27/2005 | CA2532229A1 Use of parthenolide derivatives as antileukemic and cytotoxic agents |
| 01/27/2005 | CA2531535A1 Substituted quinolin-4-ylamine analogues |
| 01/26/2005 | EP1499619A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof |
| 01/26/2005 | EP1499618A1 Furyl compounds |
| 01/26/2005 | EP1499617A1 Camptothecin-taxoid conjugates as antimitotic and antitumor agents |
| 01/26/2005 | EP1499616A1 Heterocyclic compounds |
| 01/26/2005 | EP1499615A1 Thienyl compounds |
| 01/26/2005 | EP1499609A2 Pesticidal heterocycles |
| 01/26/2005 | EP1499305A2 Use of ep4 receptor ligands in the treatment of il-6 involved diseases |
| 01/26/2005 | EP1427727B1 Compounds which inhibit the release of inflammatory cytokines |
| 01/26/2005 | EP0975637B1 Amidino-camptothecin derivatives |
| 01/26/2005 | EP0958514B1 Novel photochromic heterocyclic fused indenonaphthopyrans |
| 01/26/2005 | CN1571789A Himbacine analogues as thrombin receptor antagonists |
| 01/26/2005 | CN1569857A Method and technology for resin absorption purification of lycoris radiate galanthamine hydrobromide from alkaloid |
| 01/26/2005 | CN1569856A Method and technology for acid water extracting of lycoris radiate galanthamine hydrobromide from alkaloid |
| 01/26/2005 | CN1186324C Condensed heteroaryl derivatives |
| 01/25/2005 | CA2309352C Heterocyclic-substituted tricyclics as thrombin receptor antagonists |
| 01/25/2005 | CA2103383C Quinazoline derivatives |
| 01/20/2005 | WO2005005600A2 Camptothecin analogs having an e-ring ketone |
| 01/20/2005 | WO2005005431A2 7-polyaminoalkyl(oxy)iminomethylcamptothecins bearing protective groups |
| 01/20/2005 | WO2005005430A2 Process for the preparation of furopyrroles |
| 01/20/2005 | WO2005005397A1 5-substituted quinazolinone derivatives |
| 01/20/2005 | WO2005004801A2 Indole, azaindole and related heterocyclic n-substituted piperazine derivatives |
| 01/20/2005 | WO2004099124A3 Novel bioisosteres of actinonin |
| 01/20/2005 | WO2004089926A8 Genipin derivatives and uses thereof |
| 01/20/2005 | WO2004073601A3 Process for the preparation of hexacyclic camptothecin derivatives |
| 01/20/2005 | WO2004069792A3 Quinoline-derived amide modulators of vanilloid vr1 receptor |
| 01/20/2005 | WO2003076443A9 Spiro compounds with npy antagonistic activity |
| 01/20/2005 | US20050014953 Method for the racemization of etodolic acid |
| 01/20/2005 | US20050014802 Prevent reproduction of virus; antitumor agents |
| 01/20/2005 | US20050014775 Anticancer agents |
| 01/20/2005 | US20050014771 fused thienopyrimidine compounds useful as phosphatidylinositol 3-kinase inhibitors and carcinostatic agents |
| 01/20/2005 | US20050014769 Anticancer agents; controlling apoptosis |
| 01/20/2005 | DE10329860A1 Sulfonamidderivate polycyclischer Farbstoffe für analytische Anwendungen Sulfonamide derivatives of polycyclic dyes for analytical applications |